The United States, Eli Lilly, and Novo Nordisk AS announced an agreement to lower the price of GLP-1 weight loss drugs, with both companies pricing it at $245 per month

华尔街见闻
2025.11.06 17:05

美国、礼来、诺和诺德宣布关于降低 GLP-1 减肥药价格的协议，两家公司定价每个月 245 美元。风险提示及免责条款 市场有风险，投资需谨慎。本文不构成个人投资建议，也未考虑到个别用户特殊的投资目标、财务状况或需要。用户应考虑本文中的任何意见、观点或结论是否符合其特定状况。据此投资，责任自负。

美国、礼来、诺和诺德宣布关于降低 GLP-1 减肥药价格的协议，两家公司定价每个月 245 美元。

风险提示及免责条款

市场有风险，投资需谨慎。本文不构成个人投资建议，也未考虑到个别用户特殊的投资目标、财务状况或需要。用户应考虑本文中的任何意见、观点或结论是否符合其特定状况。据此投资，责任自负。

Source: 华尔街见闻 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.